• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载三磷酸腺苷的仿生纳米颗粒作为细胞外药物在癌症应用中的控释系统。

ATP-loaded biomimetic nanoparticles as controlled release system for extracellular drugs in cancer applications.

机构信息

Laboratory of Pharmacology, Deparment of Biology, Faculty of Chemistry and Biology, Center for the Development of Nanoscience and Nanotechnology, University of Santiago de Chile, Santiago, Chile,

出版信息

Int J Nanomedicine. 2019 Apr 5;14:2433-2447. doi: 10.2147/IJN.S192925. eCollection 2019.

DOI:10.2147/IJN.S192925
PMID:31040666
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6454990/
Abstract

PURPOSE

The antitumoral effect of ATP requires its accumulation in the extracellular space to interact with membrane receptors in target cells. We propose the use of albumin nanoparticles (ANPs) coated with erythrocyte membranes (EMs) to load, deliver, release, and enhance the extracellular anticancer activity of ATP.

MATERIALS AND METHODS

ANPs were synthesized by desolvation method and optimal values of pH, albumin concentration, and ethanol volume were determined. EMs were derived from erythrocyte lysates and were coated on to ANPs using an extruder. Size was determined by transmission electron microscopy (TEM) and hydrodynamic size and zeta potential were determined by dynamic light scattering. Coating of the ANPs with the EMs was verified by TEM and confocal microscopy. Nanoparticle cell uptake was analyzed by confocal microscopy using HeLa and HEK-293 cell cultures treated with nanoparticles stained with 1,1'-diocta-decyl-3,3,3',3'-tetramethylindodicarbocyanine, 4-chlorobenzenesulfonate salt (DiD) for EM-ANPs and Alexa 488 for ANPs. Cell viability was analyzed by [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt (MTS) and Annexin V/propidium iodide assays.

RESULTS

Optimal values of ANP preparation were as follows: pH=9, 10 mg/mL albumin concentration, and 2.33±0.04 mL ethanol volume. Size distributions as analyzed by TEM were as follows: ANPs =91.9±4.3 nm and EM-ANPs =98.3±5.1 nm; hydrodynamic sizes: ANPs =180.5±6.8 nm and EM-ANPs =197.8±3.2 nm; and zeta potentials: ANPs =17.8±3.5 mV, ANPs+ATP =-13.60±0.48 and EM-ANPs =-13.7±2.9 mV. The EMs coating the ANPs were observed by TEM and confocal microscopy. A fewer number of internalized EM-ANPs+ATP compared to non-coated ANPs+ATP was observed in HeLa and HEK-293 cells. Cell viability decreased up to 48.6%±2.0% with a concentration of 400 µM ATP after 72 hours of treatment and cell death is caused mainly via apoptosis.

CONCLUSION

Our current results show that it is possible to obtain nanoparticles from highly biocompatible, biodegradable materials and that their coating with EMs allows the regulation of the internalization process in order to promote extracellular activity of ATP.

摘要

目的

ATP 的抗肿瘤作用需要其在细胞外空间积累,以与靶细胞的膜受体相互作用。我们建议使用红细胞膜(EM)包被的白蛋白纳米颗粒(ANPs)来负载、输送、释放和增强 ATP 的细胞外抗癌活性。

材料和方法

通过去溶剂法合成 ANPs,并确定最佳 pH 值、白蛋白浓度和乙醇体积。EM 来源于红细胞裂解物,并使用挤出机涂覆在 ANPs 上。通过透射电子显微镜(TEM)确定粒径,通过动态光散射法确定水动力粒径和 zeta 电位。通过 TEM 和共聚焦显微镜验证 ANPs 与 EM 的包覆。使用 HeLa 和 HEK-293 细胞培养物,用 1,1'-二辛基-3,3,3',3'-四甲基吲哚羰花青,4-氯苯磺酸盐(DiD)对 EM-ANPs 进行染色,用 Alexa 488 对 ANPs 进行染色,通过共聚焦显微镜分析纳米颗粒的细胞摄取。通过 [3-(4,5-二甲基噻唑-2-基)-5-(3-羧基甲氧基苯基)-2-(4-磺基苯基)-2H-四唑,内盐(MTS)和 Annexin V/碘化丙啶测定分析细胞活力。

结果

ANP 制备的最佳条件为:pH=9、10mg/mL 白蛋白浓度和 2.33±0.04mL 乙醇体积。TEM 分析的粒径分布如下:ANPs=91.9±4.3nm 和 EM-ANPs=98.3±5.1nm;水动力粒径:ANPs=180.5±6.8nm 和 EM-ANPs=197.8±3.2nm;和 zeta 电位:ANPs=17.8±3.5mV、ANPs+ATP=-13.60±0.48 和 EM-ANPs=-13.7±2.9mV。通过 TEM 和共聚焦显微镜观察到 ANPs 包被的 EM。与未包被的 ANPs+ATP 相比,HeLa 和 HEK-293 细胞中内化的 EM-ANPs+ATP 数量较少。用 400µM ATP 处理 72 小时后,细胞活力下降至 48.6%±2.0%,细胞死亡主要通过凋亡引起。

结论

我们目前的结果表明,有可能从高度生物相容、可生物降解的材料中获得纳米颗粒,并且它们与 EM 的包覆可以调节内化过程,以促进 ATP 的细胞外活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2a/6454990/715aec0281da/ijn-14-2433Fig10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2a/6454990/5cca28a4597a/ijn-14-2433Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2a/6454990/b30e00f8e472/ijn-14-2433Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2a/6454990/31cb51cf19e9/ijn-14-2433Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2a/6454990/398a0ee1f177/ijn-14-2433Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2a/6454990/696697384cef/ijn-14-2433Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2a/6454990/11145ad55604/ijn-14-2433Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2a/6454990/4d14ce0428c4/ijn-14-2433Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2a/6454990/752e98c0de96/ijn-14-2433Fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2a/6454990/7d14079f8474/ijn-14-2433Fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2a/6454990/715aec0281da/ijn-14-2433Fig10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2a/6454990/5cca28a4597a/ijn-14-2433Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2a/6454990/b30e00f8e472/ijn-14-2433Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2a/6454990/31cb51cf19e9/ijn-14-2433Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2a/6454990/398a0ee1f177/ijn-14-2433Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2a/6454990/696697384cef/ijn-14-2433Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2a/6454990/11145ad55604/ijn-14-2433Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2a/6454990/4d14ce0428c4/ijn-14-2433Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2a/6454990/752e98c0de96/ijn-14-2433Fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2a/6454990/7d14079f8474/ijn-14-2433Fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2a/6454990/715aec0281da/ijn-14-2433Fig10.jpg

相似文献

1
ATP-loaded biomimetic nanoparticles as controlled release system for extracellular drugs in cancer applications.载三磷酸腺苷的仿生纳米颗粒作为细胞外药物在癌症应用中的控释系统。
Int J Nanomedicine. 2019 Apr 5;14:2433-2447. doi: 10.2147/IJN.S192925. eCollection 2019.
2
Multifunctional albumin nanoparticles as combination drug carriers for intra-tumoral chemotherapy.多功能白蛋白纳米粒作为肿瘤内化疗的联合药物载体。
Adv Healthc Mater. 2013 Sep;2(9):1236-45. doi: 10.1002/adhm.201200467. Epub 2013 Mar 12.
3
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform.红细胞膜伪装的聚合物纳米颗粒作为仿生递药平台。
Proc Natl Acad Sci U S A. 2011 Jul 5;108(27):10980-5. doi: 10.1073/pnas.1106634108. Epub 2011 Jun 20.
4
Redox responsive albumin autogenic nanoparticles for the delivery of cancer drugs.用于递送抗癌药物的氧化还原响应性白蛋白自组装纳米颗粒
Colloids Surf B Biointerfaces. 2017 Apr 1;152:393-405. doi: 10.1016/j.colsurfb.2017.01.044. Epub 2017 Jan 25.
5
Acid-responsive nanoparticles as a novel oxidative stress-inducing anticancer therapeutic agent for colon cancer.酸响应性纳米颗粒作为一种新型氧化应激诱导型结肠癌治疗药物。
Int J Nanomedicine. 2019 Feb 28;14:1597-1618. doi: 10.2147/IJN.S189923. eCollection 2019.
6
Design, optimization, and evaluation of methotrexate loaded and albumin coated polymeric nanoparticles.载甲氨蝶呤白蛋白包覆聚合物纳米粒的设计、优化与评价。
J Biomater Sci Polym Ed. 2024 Sep;35(13):2068-2089. doi: 10.1080/09205063.2024.2366619. Epub 2024 Jun 18.
7
Biofunctionalized polymer-lipid supported mesoporous silica nanoparticles for release of chemotherapeutics in multidrug resistant cancer cells.用于在多药耐药癌细胞中释放化疗药物的生物功能化聚合物-脂质支撑的介孔硅纳米粒子。
Biomaterials. 2014 Apr;35(11):3650-65. doi: 10.1016/j.biomaterials.2014.01.013. Epub 2014 Jan 24.
8
Long-circulating self-assembled cholesteryl albumin nanoparticles enhance tumor accumulation of hydrophobic anticancer drug.长循环自组装胆固醇基白蛋白纳米粒增强疏水性抗癌药物的肿瘤蓄积
Eur J Pharm Biopharm. 2015 Oct;96:96-105. doi: 10.1016/j.ejpb.2015.07.013. Epub 2015 Jul 23.
9
Investigation of novel superparamagnetic NiZnFeO@albumen nanoparticles for controlled delivery of anticancer drug.新型超顺磁 NiZnFeO@白蛋白纳米粒子用于抗癌药物的控制释放研究。
Nanotechnology. 2017 Sep 8;28(36):365101. doi: 10.1088/1361-6528/aa7d81. Epub 2017 Jul 4.
10
Functional Albumin Nanoformulations to Fight Adrenocortical Carcinoma: a Redox-Responsive Approach.功能性白蛋白纳米制剂对抗肾上腺皮质癌:一种氧化还原响应方法。
Pharm Res. 2020 Feb 14;37(3):55. doi: 10.1007/s11095-020-2775-4.

引用本文的文献

1
Current and Near-Future Technologies to Quantify Nanoparticle Therapeutic Loading Efficiency and Surface Coating Efficiency with Targeted Moieties.用于量化纳米颗粒治疗负载效率和靶向部分表面包被效率的当前及近期技术。
Bioengineering (Basel). 2025 Mar 31;12(4):362. doi: 10.3390/bioengineering12040362.
2
Leveraging adenosine triphosphate for cancer theranostics.利用三磷酸腺苷进行癌症诊疗。
Theranostics. 2025 Mar 24;15(10):4708-4733. doi: 10.7150/thno.106291. eCollection 2025.
3
Bovine Serum Albumin Nanoparticle-Mediated Delivery of Ribavirin and Mycophenolic Acid for Enhanced Antiviral Therapeutics.

本文引用的文献

1
Extracellular ATP and P2 purinergic signalling in the tumour microenvironment.细胞外 ATP 与肿瘤微环境中的 P2 嘌呤能信号转导。
Nat Rev Cancer. 2018 Oct;18(10):601-618. doi: 10.1038/s41568-018-0037-0.
2
Strategies for Preparing Albumin-based Nanoparticles for Multifunctional Bioimaging and Drug Delivery.用于多功能生物成像和药物递送的白蛋白纳米颗粒的制备策略。
Theranostics. 2017 Aug 23;7(15):3667-3689. doi: 10.7150/thno.19365. eCollection 2017.
3
Bottom-up synthesis of WS nanosheets with synchronous surface modification for imaging guided tumor regression.
牛血清白蛋白纳米颗粒介导的利巴韦林和霉酚酸递送用于增强抗病毒治疗
Viruses. 2025 Jan 21;17(2):138. doi: 10.3390/v17020138.
4
Factors Affecting the Synthesis of Bovine Serum Albumin Nanoparticles Using the Desolvation Method.采用去溶剂化法合成牛血清白蛋白纳米颗粒的影响因素
Nanotechnol Sci Appl. 2024 Jan 31;17:21-40. doi: 10.2147/NSA.S441324. eCollection 2024.
5
Biomimetic Antidote Nanoparticles: a Novel Strategy for Chronic Heavy Metal Poisoning.仿生解毒纳米颗粒:慢性重金属中毒的新策略。
AAPS PharmSciTech. 2022 Nov 30;24(1):12. doi: 10.1208/s12249-022-02466-8.
6
An overview of resistance to chemotherapy in osteosarcoma and future perspectives.骨肉瘤化疗耐药概述及未来展望。
Cancer Drug Resist. 2022 Jun 23;5(3):762-793. doi: 10.20517/cdr.2022.18. eCollection 2022.
7
Immunogenic Cell Death: A Step Ahead of Autophagy in Cancer Therapy.免疫原性细胞死亡:癌症治疗中领先于自噬的一步。
J Cancer Immunol (Wilmington). 2021;3(1):47-59. doi: 10.33696/cancerimmunol.3.041.
8
Extracellular ATP: A Feasible Target for Cancer Therapy.细胞外 ATP:癌症治疗的可行靶点。
Cells. 2020 Nov 17;9(11):2496. doi: 10.3390/cells9112496.
9
Tooth Formation: Are the Hardest Tissues of Human Body Hard to Regenerate?牙齿形成:人体最坚硬的组织难以再生吗?
Int J Mol Sci. 2020 Jun 4;21(11):4031. doi: 10.3390/ijms21114031.
10
Emerging Biomimetic Materials for Studying Tumor and Immune Cell Behavior.新兴仿生材料在肿瘤与免疫细胞行为研究中的应用
Ann Biomed Eng. 2020 Jul;48(7):2064-2077. doi: 10.1007/s10439-019-02384-0. Epub 2019 Oct 15.
用于成像引导肿瘤消退的具有同步表面修饰的 WS 纳米片的自下而上合成。
Acta Biomater. 2017 Aug;58:442-454. doi: 10.1016/j.actbio.2017.06.014. Epub 2017 Jun 10.
4
Comparison of Avidin, Neutravidin, and Streptavidin as Nanocarriers for Efficient siRNA Delivery.抗生物素蛋白、中性抗生物素蛋白和链霉抗生物素蛋白作为高效小干扰RNA递送纳米载体的比较
Mol Pharm. 2017 May 1;14(5):1517-1527. doi: 10.1021/acs.molpharmaceut.6b00933. Epub 2017 Jan 13.
5
A simple improved desolvation method for the rapid preparation of albumin nanoparticles.一种用于快速制备白蛋白纳米颗粒的简单改进去溶剂化方法。
Int J Biol Macromol. 2016 Oct;91:703-9. doi: 10.1016/j.ijbiomac.2016.05.032. Epub 2016 May 10.
6
Intracellular trafficking and exocytosis of a multi-component siRNA nanocomplex.多组分小干扰RNA纳米复合物的细胞内运输与胞吐作用
Nanomedicine. 2016 Jul;12(5):1323-34. doi: 10.1016/j.nano.2016.02.003. Epub 2016 Mar 10.
7
In vivo biocompatibility, clearance, and biodistribution of albumin vehicles for pulmonary drug delivery.用于肺部药物递送的白蛋白载体的体内生物相容性、清除率和生物分布。
J Control Release. 2015 Jul 28;210:1-9. doi: 10.1016/j.jconrel.2015.05.269. Epub 2015 May 14.
8
Continuous intravenous infusion of ATP in humans yields large expansions of erythrocyte ATP pools but extracellular ATP pools are elevated only at the start followed by rapid declines.在人体中持续静脉输注三磷酸腺苷(ATP)会使红细胞中的ATP储备大幅增加,但细胞外ATP储备仅在开始时升高,随后迅速下降。
Purinergic Signal. 2015 Jun;11(2):251-62. doi: 10.1007/s11302-015-9450-y. Epub 2015 Apr 29.
9
Effect of the surface modification, size, and shape on cellular uptake of nanoparticles.表面修饰、尺寸和形状对纳米颗粒细胞摄取的影响。
Cell Biol Int. 2015 Aug;39(8):881-90. doi: 10.1002/cbin.10459. Epub 2015 Apr 29.
10
Stabilization and cellular delivery of chitosan-polyphosphate nanoparticles by incorporation of iron.铁的掺入稳定和细胞递呈壳聚糖-多聚磷酸盐纳米粒。
J Control Release. 2014 Nov 28;194:211-9. doi: 10.1016/j.jconrel.2014.08.022. Epub 2014 Sep 1.